Breaking News

Evotec, Haplogen in Infectious Disease Pact

November 15, 2012

Will co-develop drugs against viruses

Evotec and Haplogen have signed a collaboration agreement to discover and develop small molecules against viral infectious diseases. Financial terms were not disclosed.
 
The companies will co-develop drugs against a human protein that is essential for pathogenic viruses to infect their host cell. This protein was discovered by Haplogen’s technology that identifies host factors for infectious pathogens. Evotec will further develop lead compounds and apply its drug discovery platform to find additional small molecule inhibitors.
 
“This partnership will ensure that our therapeutic program advances with increasing pace to discover molecules for clinical testing in those patients that are at high risk of virus infections,” said Georg Casari, chief executive officer of Haplogen. “We are excited that Evotec shares our vision and has joined forces on this first-in-class drug target.”
 
Mario Polywka, chief operating officer of Evotec, said, “Part of Evotec’s strategy is to pursue innovative, early stage projects and develop them to a partnering position before the clinic. We are delighted to partner with Haplogen to optimize their protein inhibitors. Haplogen’s powerful target discovery technology is an excellent complement to Evotec’s small molecule discovery and development capabilities. We hope that this is the start of a long-term relationship.”
 

Related Contract Manufacturing:

blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.